DIANE O'CONNOR: Open Payments
NPI 1376735670 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 47 payments from 11 companies in 2025. Trend: 2023 $999 · 2024 $647 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $326 |
| GlaxoSmithKline, LLC. | 10 | $297 |
| AstraZeneca Pharmaceuticals LP | 5 | $199 |
| Novartis Pharmaceuticals Corporation | 8 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $111 |
| CSL Behring | 4 | $102 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| BioCryst US Sales Co., LLC | 2 | $59 |
| Grifols USA, LLC | 1 | $34 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, Rhapsido, Hizentra, CUVITRU, ORLADEYO, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
